CDC Panel Favors Wider Use of Pfizer, Merck Pneumococcal Shots
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and ...
Merck acquires cancer drug startup; Elevidys ex-US sales rise
Yale spinout Modifi has agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to ...
Merck & Company (MRK) Receives a Buy from Jefferies
In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...
Merck KGaA Trims Health Care And Life Sciences Targets, Eyes M&A
Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?
We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates ...
Merck & Company (MRK) Receives a Buy from Berenberg Bank
Berenberg Bank analyst Luisa Hector maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a price ...
Merck's RSV antibody for infants effective in reducing some types of infections in study
Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...
Merck KGaA Shares Jump on Expectations of AI Boost
Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
"It is integrated into everything that we do," says Merck's chief information and digital officer Dave Williams.